Document is current
Any future updates will be listed below
-
Authors
Cullell, Natalia
Soriano-Tárraga, Carolina
Gallego-Fábrega, Cristina
Cárcel-Márquez, Jara
Muiño, Elena
Llucià-Carol, Laia
Lledós, Miquel
Esteller, Manel
de Moura, Manuel Castro
Montaner, Joan
Rosell, Anna
Delgado, Pilar
Martí-Fábregas, Joan
Krupinski, Jerzy
Roquer, Jaume
Jiménez-Conde, Jordi
Fernández-Cadenas, Israel
-
Funding
Funding for this research was provided by:
Boehringer Ingelheim España (SEDMAN STUDY, SEDMAN STUDY)
Instituto de Salud Carlos III (RETICS Network INVICTUS + and the RICORDS Stroke network, CD20/00043, CM18/00198, FI19/00309, RETICS Network INVICTUS + and the RICORDS Stroke network, RETICS Network INVICTUS + and the RICORDS Stroke network, RETICS Network INVICTUS + and the RICORDS Stroke network, PI17/02089, RETICS Network INVICTUS + and the RICORDS Stroke network, RETICS Network INVICTUS + and the RICORDS Stroke network, PI18/01338)
Agència de Gestió d'Ajuts Universitaris i de Recerca (2019_FI_B 00853, 2017SGR-1427)
FUNDACIÓ DOCÈNCIA I RECERCA MÚTUATERRASSA (EPIGENESIS STUDY)
Bristol-Myers Squibb (APHAS Study)
Eranet-Neuron (iBioStroke project)
Fundació la Marató de TV3 (Epigenesis)
- License Information
-
More Information
Article History
Received: 20 May 2022
Accepted: 13 September 2022
First Online: 30 September 2022
Declarations
:
: The study was approved by the ethics committees of all the participant hospitals (the promoter committees were: Comité Ético de Investigación Clínica del Parc de Salut Mar, Comitè Ètic d'Investigació Clínica de l'Hospital Universitari Vall d'Hebron and Comitè ètic de l’Hospital MútuaTerrassa). All participants provided written informed consent to participate.
: Not applicable.
: The authors declare no competing interests.
